Caterina Casari

1.8k total citations
58 papers, 1.3k citations indexed

About

Caterina Casari is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Caterina Casari has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 14 papers in Immunology and 9 papers in Surgery. Recurrent topics in Caterina Casari's work include Platelet Disorders and Treatments (45 papers), Blood groups and transfusion (22 papers) and Complement system in diseases (12 papers). Caterina Casari is often cited by papers focused on Platelet Disorders and Treatments (45 papers), Blood groups and transfusion (22 papers) and Complement system in diseases (12 papers). Caterina Casari collaborates with scholars based in France, United States and Netherlands. Caterina Casari's co-authors include Peter J. Lenting, Cécile V. Denis, Olivier D. Christophe, Paulette Legendre, Nikolett Wohner, Julie Pegon, Wolfgang Bergmeier, Alexandre Kauskot, Ana‐Maria Navarrete and Vincent Muczynski and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Caterina Casari

54 papers receiving 1.3k citations

Peers

Countries citing papers authored by Caterina Casari

Since Specialization

Citations

This map shows the geographic impact of Caterina Casari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Casari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Casari more than expected).

Fields of papers citing papers by Caterina Casari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caterina Casari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Casari. The network helps show where Caterina Casari may publish in the future.

Co-authorship network of co-authors of Caterina Casari

This figure shows the co-authorship network connecting the top 25 collaborators of Caterina Casari. A scholar is included among the top collaborators of Caterina Casari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caterina Casari. Caterina Casari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	<i>Erratum</i> to: “Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice” 2025 ·Haematologica ·(unknown), (unknown), Marie‐Annick Clavel, (unknown), Ivan Peyron, Tovo David, Camille Brochier, François Saller, (unknown), Cécile V. Denis, Olivier D. Christophe, Peter J. Lenting, Vincent Muczynski, Caterina Casari	0
2	Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice 2025 ·Haematologica ·(unknown), (unknown), Marie‐Annick Clavel, (unknown), Ivan Peyron, Tovo David, Camille Brochier, François Saller, (unknown), Cécile V. Denis, Olivier D. Christophe, Peter J. Lenting, Vincent Muczynski, Caterina Casari	2
3	Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs 2025 ·Blood Advances ·(unknown), (unknown), Richard Dirven, (unknown), Ruben Bierings, Caterina Casari, Robert A. Cordfunke, James E. Dahlman, (unknown), Jan W. Drijfhout, Frank W.G. Leebeek, L. Renee Ruhaak, Elisa Schrader Echeverri, Jan Voorberg, Bart J.M. van Vlijmen, Cécile V. Denis, Jeroen Eikenboom	6
4	Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibody 2025 ·Blood ·Vincent Muczynski, Olivier D. Christophe, (unknown), (unknown), Alain P. Guérin, Caterina Casari, Jenny McIntosh, (unknown), (unknown), Satyen H. Gohil, Peter J. Lenting, Edward G. D. Tuddenham, Amit Nathwani	0
5	A bispecific nanobody for the treatment of von Willebrand disease type 1 2025 ·Blood ·Ivan Peyron, Caterina Casari, (unknown), (unknown), (unknown), (unknown), (unknown), Stéphanie Roullet, Sophie Susen, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis	1
6	Historical, current and future treatments for von Willebrand disease 2025 ·Haematologica ·Caterina Casari, (unknown), (unknown)	0
7	Advances in Von Willebrand Disease 2025 ·Haemophilia ·Riitta Lassila, Ferdows Atiq, Caterina Casari, Michelle Lavin	0
8	von Willebrand factor: from figurant to main character in the scene of inflammation 2023 ·Journal of Thrombosis and Haemostasis ·Peter J. Lenting, (unknown), Caterina Casari	1
9	Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in Von Willebrand disease murine models 2023 ·Blood ·Stéphanie Roullet, (unknown), Julie Rayes, (unknown), (unknown), Andrew J. Ditto, (unknown), Christa L. Pawlowski, (unknown), Frédéric Adam, Caterina Casari, Olivier D. Christophe, Michael A. Bruckman, Peter J. Lenting, Anirban Sen Gupta, Cécile V. Denis	19
10	KB-V13A12, a novel nanobody-based therapeutic molecule for the treatment of von Willebrand disease 2023 ·SPIRE - Sciences Po Institutional REpository ·Ivan Peyron, Caterina Casari, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis	2
11	OC 08.3 KB-V13A12, a Novel Nanobody-based Therapeutic Molecule for the Treatment of Von Willebrand Disease 2023 ·Research and Practice in Thrombosis and Haemostasis ·Ivan Peyron, Caterina Casari, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis	7
12	Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization 2022 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Ivan Peyron, (unknown), Serge Pierre‐Louis, (unknown), Pierre Boisseau, Annika de Jong, Sophie Susen, Jenny Goudemand, Rémi Nevière, (unknown), Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis, Caterina Casari	2
13	A compact integrated microfluidic oxygenator with high gas exchange efficiency and compatibility for long-lasting endothelialization 2021 ·Lab on a Chip ·(unknown), Gilgueng Hwang, Nassim Arouche, Sina Naserian, Abdelmounaïm Harouri, Valeria Lotito, Caterina Casari, (unknown), (unknown), (unknown), Julien Guihaire, Cécile V. Denis, Peter J. Lenting, Abdul I. Barakat, Georges Uzan, Olaf Mercier, Anne‐Marie Haghiri‐Gosnet	17
14	Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor 2021 ·Gene Therapy ·Elena Barbon, Charlotte Kawecki, Solenne Marmier, (unknown), Fanny Collaud, Séverine Charles, Giuseppe Ronzitti, Caterina Casari, Olivier D. Christophe, Cécile V. Denis, Peter J. Lenting, Federico Mingozzi	25
15	Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications 2020 ·Research and Practice in Thrombosis and Haemostasis ·Ivan Peyron, (unknown), (unknown), (unknown), (unknown), Cécile V. Denis, Peter J. Lenting, Caterina Casari, Olivier D. Christophe	10
16	A hemophilia A mouse model for the in vivo assessment of emicizumab function 2020 ·Blood ·(unknown), Ivan Peyron, Olivier D. Christophe, Charlotte Kawecki, Caterina Casari, Vincent Muczynski, Amit Nathwani, Alexandre Kauskot, Peter J. Lenting, Cécile V. Denis	44
17	Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors 2020 ·EMBO Molecular Medicine ·Elena Barbon, (unknown), (unknown), Jean‐François Ottavi, Charlotte Kawecki, Caterina Casari, (unknown), Solenne Marmier, Laetitia van Wittenberghe, Séverine Charles, Fanny Collaud, Cécile V. Denis, Olivier D. Christophe, Federico Mingozzi, Peter J. Lenting	19
18	Desialylation of <i>O</i>-glycans on glycoprotein Ibα drives receptor signaling and platelet clearance 2020 ·Haematologica ·Yingchun Wang, Wenchun Chen, Wei Zhang, (unknown), Caterina Casari, Michael C. Berndt, François Lanza, Wolfgang Bergmeier, Karin M. Hoffmeister, Xiao Hui Zhang, Renhao Li	27
19	Deletion of the Arp2/3 complex in megakaryocytes leads to microthrombocytopenia in mice 2017 ·Blood Advances ·David S. Paul, Caterina Casari, Congying Wu, Raymond Piatt, (unknown), Robert A. Campbell, (unknown), Dorsaf Ghalloussi, Robert H. Lee, Jeremy D. Rotty, Brian C. Cooley, Kellie R. Machlus, Joseph E. Italiano, (unknown), James E. Bear, Wolfgang Bergmeier	38
20	Terminal Platelet Production is Regulated by Von Willebrand Factor 2013 ·PLoS ONE ·Sonia Poirault‐Chassac, Kim Nguyen, (unknown), Caterina Casari, Agnès Veyradier, Cécile V. Denis, Dominique Baruch	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact